CompaniesBiotheus

Biotheus

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (24)
View all

Total Trials

24

As Lead Sponsor

18

As Collaborator

6

Total Enrollment

6,743

By Phase

PHASE2: 7PHASE1/PHASE2: 8PHASE3: 3PHASE2/PHASE3: 1PHASE1: 3NA: 1

By Status

RECRUITING: 11ACTIVE_NOT_RECRUITING: 6UNKNOWN: 4NOT_YET_RECRUITING: 3
Clinical Trials Pipeline24 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
Today
NCT04280497
NCT05918445
NCT05862831
NCT05867771
NCT05864105
NCT05950815
NCT05879068
NCT05918133
NCT05839106
NCT05918107
NCT05879055
NCT05844150
NCT05756972
NCT05537051
NCT06419621
NCT06616532
NCT06584071
NCT06712316
NCT06712355
NCT06827236
NCT06892548
NCT07133750
Hover over trial bars to see details

Recent Trials

NCT07133750Lead Sponsor
PM8002 (BNT327) in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer
PHASE2Not yet recruiting
40 participants
Started: Aug 31, 2025 · Completed: Aug 31, 2029
NCT06892548Collaborator
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
PHASE1/PHASE2Recruiting
594 participants
Started: May 2, 2025 · Completed: Jun 30, 2031
NCT06827236Collaborator
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
PHASE1/PHASE2Recruiting
380 participants
Started: Apr 23, 2025 · Completed: May 31, 2029
NCT06712355Collaborator
Safety and Effectiveness of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
PHASE3Active, not recruiting
439 participants
Started: Feb 3, 2025 · Completed: Sep 30, 2028
NCT06712316Collaborator
Safety, Effectiveness, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
PHASE2/PHASE3Recruiting
982 participants
Started: Jan 7, 2025 · Completed: Dec 31, 2030
View all 24 trials →
Related Companies
Biontech
acquired